Formetorex
Names | |
---|---|
Preferred IUPAC name N-(1-Phenylpropan-2-yl)formamide | |
Other names Formetorex N-Formylamphetamine N-(alpha-Methylphenethyl)formamide | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
Beilstein Reference | 1563 |
ChEMBL |
|
ChemSpider |
|
PubChem CID |
|
UNII |
|
CompTox Dashboard (EPA) |
|
InChI
| |
| |
Properties | |
Chemical formula | C10H13NO |
Molar mass | 163.220 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references |
Formetorex (INN), also known as formetamide or N-formylamphetamine, is a substituted amphetamine described as an anorectic which does not appear to have ever been marketed.[1]
Formetorex is also an intermediate in the production of amphetamine by the "Leuckart reaction."[2] It is also commonly found as an impurity in clandestine labs where this synthesis method is used.[2][3] Due to the simplicity of the Leuckart reaction, it is the most popular synthetic route employed for the illicit manufacture of amphetamines.[2] The synthesis involves a non-metal reduction that is typically carried out in three steps.[2] For amphetamine synthesis, a mixture of phenylacetone and formamide (sometimes in the presence of formic acid) or ammonium formate, is heated until a condensation reaction results in the intermediate product, formetamide.[2] In the second step, formetamide is hydrolysed using hydrochloric acid, and the reaction mixture is then basified, isolated, and steam distilled to produce the free base.[2] The final step, the product is dissolved in an organic solvent and precipitated as the sulphate salt of amphetamine by adding sulfuric acid.[2]
Amphetamine synthesis via the Leuckart reaction |
References
- ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 568–. ISBN 978-0-412-46630-4.
- ^ a b c d e f g Laboratory and Scientific Section (2006). Recommended methods of the identification and analysis of amphetamine, methamphetamine, and their ring-substituted analogues in seized materials (PDF). New York: United Nations Office on Drugs and Crime Vienna. ISBN 92-1-148208-9. Retrieved 14 October 2013.
- ^ Kram TC (July 1979). "Reidentification of a major impurity in illicit amphetamine". Journal of Forensic Sciences. 24 (3): 596–9. doi:10.1520/JFS10875J. PMID 541629.
External links
- formetamide at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- v
- t
- e
and
pharmaceuticals
Amphetamine |
|
---|---|
Levoamphetamine | N/A |
Dextroamphetamine |
|
Lisdexamfetamine |
|
Biomolecular targets |
|
---|---|
Inhibited transporters |
- ADHD
- ADHD management
- Amphetamine psychosis
- Benzedrine in popular culture
- Dopamine
- Doping in sport
- Executive functions
- Formetorex
- ΔFosB
- History and culture of substituted amphetamines
- Methamphetamine
- Methylphenidate
- N-Methylphenethylamine
- Motivational salience
- Narcolepsy
- Neurobiological effects of physical exercise § Attention deficit hyperactivity disorder
- Nootropic
- Norepinephrine
- Obesity
- Performance-enhancing substance
- Phenethylamine
- Phentermine
- Phenylacetone
- Recreational drug use
- Serotonin
- Substituted amphetamine
- Trace amine
- Category
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e